Early Data With Copanlisib/Nivolumab Combo Support Further Exploration in MSS CRC

Eric S. Christenson, MD, discusses the potential benefit of copanlisib plus nivolumab in PIK3CA-mutant microsatellite stable colorectal cancer.

Related Keywords

Maryland ,United States ,Erics Christenson , ,Johns Hopkins Medicine ,